Guardion Health Sciences (GHSI) Short Interest Ratio & Short Volume → Trump Reveals Conspiracy Behind Fed-Controlled Digital Currency. (From Monetary Gold) (Ad) Free GHSI Stock Alerts $8.55 -0.09 (-1.04%) (As of 09:30 AM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media Guardion Health Sciences Short Interest DataCurrent Short Volume147,600 sharesPrevious Short Volume148,200 sharesChange Vs. Previous Month-0.40%Dollar Volume Sold Short$1.17 millionShort Interest Ratio / Days to Cover8.9Last Record DateApril 30, 2024Outstanding Shares1,280,000 sharesFloat Size1,030,000 sharesShort Percent of Float14.33%Today's Trading Volume287 sharesAverage Trading Volume145,957 sharesToday's Volume Vs. Average0% Short Selling Guardion Health Sciences ? Sign up to receive the latest short interest report for Guardion Health Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatGHSI Short Interest Over TimeGHSI Days to Cover Over TimeGHSI Percentage of Float Shorted Over Time Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… Guardion Health Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024147,600 shares $1.17 million -0.4%14.3%8.9 $7.90 4/15/2024148,200 shares $1.17 million +6.0%14.4%0.7 $7.89 3/31/2024139,800 shares $1.26 million +14.2%13.7%0.7 $9.03 3/15/2024122,400 shares $993,888.00 -5.3%12.0%0.6 $8.12 2/29/2024129,200 shares $1.08 million -16.8%12.7%0.6 $8.34 2/15/2024155,300 shares $1.30 million +61.8%15.2%0.8 $8.39 Get the Latest News and Ratings for GHSI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Guardion Health Sciences and its competitors with MarketBeat's FREE daily newsletter. 1/31/202496,000 shares $804,480.00 -6.0%9.4%0.5 $8.38 1/15/2024102,100 shares $529,899.00 +0.1%10.0%37.8 $5.19 12/31/2023102,000 shares $544,680.00 -3.9%10.0%34.7 $5.34 12/15/2023106,100 shares $596,282.00 -2.2%10.4%36.6 $5.62 11/30/2023108,500 shares $667,275.00 +0.4%10.6%43.4 $6.15 11/15/2023108,100 shares $597,793.00 -4.1%10.6%34.9 $5.53 10/31/2023112,700 shares $694,232.00 -0.4%11.1%34.2 $6.16 10/15/2023113,200 shares $793,532.00 -1.2%11.1%29 $7.01 9/30/2023114,600 shares $845,759.46 -2.3%11.2%25.5 $7.38 9/15/2023117,300 shares $940,746.00 +12.8%11.5%21.7 $8.02 8/31/2023104,000 shares $823,680.00 -0.5%10.2%16.1 $7.92 8/15/2023104,500 shares $822,415.00 +0.6%10.3%12.4 $7.87 7/31/2023103,900 shares $776,133.00 -7.3%10.3%10.9 $7.47 7/15/2023112,100 shares $868,214.50 +4.0%11.1%10 $7.75 6/30/2023107,800 shares $820,358.00 -5.8%10.7%9 $7.61 6/15/2023114,400 shares $779,064.00 -2.1%11.3%6 $6.81 5/31/2023116,900 shares $721,273.00 -5.0%11.6%5.9 $6.17 5/15/2023123,100 shares $773,068.00 -2.2%12.2%7 $6.28 4/30/2023125,800 shares $708,254.00 -0.9%12.5%6.9 $5.63 4/15/2023126,900 shares $747,441.00 -9.7%10.2%6.6 $5.89 3/31/2023140,600 shares $859,066.00 +11.8%11.5%5 $6.11 3/15/2023125,800 shares $644,863.38 -2.2%10.3%5.7 $5.13 2/28/2023128,600 shares $874,158.50 +0.1%10.5%5.5 $6.80 2/15/2023128,500 shares $938,050.00 +8.2%10.5%5.3 $7.30 1/31/2023118,800 shares $850,608.00 +2.1%9.7%4.8 $7.16 1/15/2023116,400 shares $942,840.00 +24.9%9.5%5 $8.10 12/30/202293,200 shares $13,523.32 -98.3%8.4%4.1 $0.15 12/15/20225,430,000 shares $881,832.00 -4.9%N/A5.1 $0.16 11/30/20225,710,000 shares $984,975.00 +2.5%N/A4.5 $0.17 11/15/20225,570,000 shares $857,780.00 +1.3%N/A4.2 $0.15 10/31/20225,500,000 shares $929,500.00 -6.1%N/A3.7 $0.17 10/15/20225,860,000 shares $951,664.00 +5.2%N/A3.4 $0.16 9/30/20225,570,000 shares $768,660.00 -13.0%N/A2.9 $0.14 9/15/20226,400,000 shares $1.11 million +3.1%N/A3 $0.17Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide GHSI Short Interest - Frequently Asked Questions What is Guardion Health Sciences' current short interest? Short interest is the volume of Guardion Health Sciences shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 147,600 shares of GHSI short. 14.33% of Guardion Health Sciences' shares are currently sold short. Learn More on Guardion Health Sciences' current short interest. What is a good short interest ratio for Guardion Health Sciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GHSI shares currently have a short interest ratio of 9.0. Learn More on Guardion Health Sciences's short interest ratio. What is a good short interest percentage for Guardion Health Sciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 14.33% of Guardion Health Sciences' floating shares are currently sold short. Is Guardion Health Sciences' short interest increasing or decreasing? Guardion Health Sciences saw a drop in short interest in the month of April. As of April 30th, there was short interest totaling 147,600 shares, a drop of 0.4% from the previous total of 148,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Guardion Health Sciences' float size? Guardion Health Sciences currently has issued a total of 1,280,000 shares. Some of Guardion Health Sciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Guardion Health Sciences currently has a public float of 1,030,000 shares. How does Guardion Health Sciences' short interest compare to its competitors? 14.33% of Guardion Health Sciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Guardion Health Sciences: Moleculin Biotech, Inc. (1.45%), MIRA Pharmaceuticals, Inc. (0.42%), Avalo Therapeutics, Inc. (10.13%), Aeterna Zentaris Inc. (0.34%), Addex Therapeutics Ltd (1.85%), Elevai Labs, Inc. (0.48%), NuCana plc (1.21%), ABVC BioPharma, Inc. (7.35%), Alterity Therapeutics Limited (1.03%), Molecular Templates, Inc. (4.68%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Guardion Health Sciences stock? Short selling GHSI is an investing strategy that aims to generate trading profit from Guardion Health Sciences as its price is falling. GHSI shares are trading up $0.14 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Guardion Health Sciences? A short squeeze for Guardion Health Sciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GHSI, which in turn drives the price of the stock up even further. How often is Guardion Health Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GHSI, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: MBRX Short Interest MIRA Short Interest AVTX Short Interest AEZS Short Interest ADXN Short Interest ELAB Short Interest NCNA Short Interest ABVC Short Interest ATHE Short Interest MTEM Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GHSI) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyWATCH: The Truth About InflationBirch GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldDoes this make you sick?Allegiance GoldTop 5 AI Stocks to Buy for 2024Market Moving Trends